Tag: B-cell non-Hodgkin lymphoma (NHL)

April 16, 2019 Off

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) – Pipeline Review, H1 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…

August 2, 2017 Off

CTI BioPharma completes enrollment in the Phase 3 trial of aggressive B-cell non-Hodgkin lymphoma drug

By Dino Mustafić

CTI BioPharma has completed enrollment in the Phase 3 PIX306 trial of PIXUVRI (pixantrone).